Skip to main content
Top
Published in: Infection 6/2017

Open Access 01-12-2017 | Brief Report

Application of the qSOFA score to predict mortality in patients with suspected infection in a resource-limited setting in Malawi

Authors: Michaëla A. M. Huson, Chawezi Katete, Lilian Chunda, Jonathan Ngoma, Claudia Wallrauch, Tom Heller, Tom van der Poll, Martin P. Grobusch

Published in: Infection | Issue 6/2017

Login to get access

Abstract

Purpose

To determine the predictive value of qSOFA (quick Sequential Organ Failure Assessment) in Malawian patients with suspected infection.

Methods

Prospective observational study in a tertiary referral hospital in Malawi.

Results

Predictive ability of qSOFA was reasonable [AUROC 0.73 (95% CI 0.68–0.78)], increasing to 0.77 (95% CI 0.72–0.82) when classifying all patients with altered mental status as high risk. Adding HIV status as a variable to the qSOFA score did not improve predictive value.

Conclusion

qSOFA is a simple tool that can aid risk stratification in resource-limited settings.
Appendix
Available only for authorised users
Literature
4.
go back to reference Harrington B, Kyriakos Vorkas C, Kanyama C, Ngoma J, Hoffman I, Hosseinipour MC. Altered mental status is an indicator of mortality and associated with both infectious and non-communicable disease in Lilongwe, Malawi. Trop Dr. 2015;45:164–7. doi:10.1177/0049475515577024. Harrington B, Kyriakos Vorkas C, Kanyama C, Ngoma J, Hoffman I, Hosseinipour MC. Altered mental status is an indicator of mortality and associated with both infectious and non-communicable disease in Lilongwe, Malawi. Trop Dr. 2015;45:164–7. doi:10.​1177/​0049475515577024​.
5.
Metadata
Title
Application of the qSOFA score to predict mortality in patients with suspected infection in a resource-limited setting in Malawi
Authors
Michaëla A. M. Huson
Chawezi Katete
Lilian Chunda
Jonathan Ngoma
Claudia Wallrauch
Tom Heller
Tom van der Poll
Martin P. Grobusch
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1057-5

Other articles of this Issue 6/2017

Infection 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine